- INDIVIDUAL PORTFOLIO
- return to portfolio listing alphabetically
Acquired by PPD in April 2009, Magen BioSciences focuses on improving the health and appearance of human skin. Magen pursues a science-driven approach to identify and develop novel therapeutics to treat a number of large, poorly served dermatological disorders. The company has assembled an outstanding science, investor and management team. The team includes co-founders of Idexx, Immunex, Alnylam, Momenta, Vertex, Biogen and Genzyme.